The company considered several attractive sites in other countries, but chose Ireland due to its thriving biotechnology community, infrastructure to support biologics manufacturing and attractive business climate.

249

The company considered several attractive sites in other countries and chose Ireland due to its thriving biotechnology community, infrastructure to support biologics manufacturing, emphasis on education, and attractive business climate, as well as the support we received from the Irish Government and IDA Ireland.

209

Amgen is pleased to establish a site in Ireland as part of our ongoing global development and manufacturing expansion. As demand for our products grows in Europe, Amgen requires capacity closer to this important market.

84